Loading...
Chemical structure of FMF-04-159-2

GC36062

FMF-04-159-2

Also known as N-[1-[3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]phenyl]sulfonylpiperidin-4-yl]-4-[(2,4,6-trichlorobenzoyl)amino]-1H-pyrazole-5-carboxamide

FMF-04-159-2 is a covalent CDK14 inhibitor· FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39·6 nM and 256 nM in NanoBRET assay, respectively

ChemicalCAS2364489-81-4MW683.01FormulaC28H30Cl3N7O5S
CAS number
2364489-81-4
Molecular weight
683.01
Formula
C28H30Cl3N7O5S
Solubility
DMSO： 250 mg/mL (366·03 mM)
InChIKey
HZPYSAHDRSBARR-QPJJXVBHSA-N
Catalogue number
GC36062
Brand
GLPBIO
Computed properties PubChem CID 138454780 · XLogP 4 · TPSA 165 Ų · H-bond donors 4
XLogP
4
TPSA
165 Ų
H-bond donors
4
H-bond acceptors
8
Rotatable bonds
10
Heavy atoms
44

SMILES CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)S(=O)(=O)N2CCC(CC2)NC(=O)C3=C(C=NN3)NC(=O)C4=C(C=C(C=C4Cl)Cl)Cl

Computed descriptors from PubChem (CID 138454780), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.